Molecular Trojan Horse Delivers Chemo Drug to Cancer Cells

News   Feb 26, 2018 | Original story from University of California, Riverside

 
Molecular Trojan Horse Delivers Chemo Drug to Cancer Cells

Schematic illustration of the developed cancer targeting agent -- 123B9 in this study. The compound (right panel) has a scorpion-like shape with two arms grabbing EphA2-expressing cancer cells, and a tail (brown) constituted by a cytotoxic chemotherapeutic agent (paclitaxel used in this work). The agent would recognize the surface of cancer cells rich in EphA2 (labeled in red in the left panel which shows cancer cells) and deliver the cytotoxic agent. Credit: Pellecchia lab, UC Riverside.

 
 
 

RELATED ARTICLES

$26.5M Study on Aggressive Prostate Cancer in African-American Men Begins

News

The largest coordinated research effort to study biological and non-biological factors associated with aggressive prostate cancer in African-American men has begun.

READ MORE

Genetic Factors Leading to Rare Bone Fusion Disorder Identified

News

Genome sequencing establishes multiple genes responsible for a rare condition that cause bone fusion

READ MORE

Processed Meats Associated with Manic Episodes

News

Analysis of over 1,000 people with and without psychiatric disorders has shown that nitrates—chemicals used to cure meats such as beef jerky, salami, hot dogs and other processed meat snacks—may contribute to mania, an abnormal mood state.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy